Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

<< Previous

Bullboard Posts

Next >>

Post by buddyboybruceon Dec 15, 2022 7:50am

220 Views

Post# 35172602

Omicron variant Covid-19 --- TSX:MBX

There will be another Covid-19 variant that will dominate headlines and cause testing line-ups around the block. This is unfortunately the truth with corona-type viruses. They mutate fast.
Microbix positioned for spike in testing. Strong close yesterday. I see a 50 cent close by end of this week, then 75 cents by year end.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China